<?xml version="1.0" encoding="UTF-8"?>
<p id="p0125">Drug repurposing methods are principally based on the analysis of biological data that make it possible to generate the hypotheses for rediscovery of available compounds for novel solutions in clinical practice and has been extensively reviewed elsewhere (
 <xref rid="bib46" ref-type="bibr">Pushpakom etÂ al., 2019</xref>). Here we summarize the most common computational drug repurposing approaches, and we detail the 
 <italic>in silico</italic> drug repurposing studies of the current global health problem COVID-19.
</p>
